Abstract
AbstractConducting ADME studies on new drug candidates remains one of the primary uses of isotopically labelled compounds. In this session, the synthesis of isotopically labelled (2H, 3H, and 14C) compounds for this purpose has been discussed. Coupling the use of AMS and isotopically labelled compounds for studies in neonatal research and care is also highlighted. Copyright © 2010 John Wiley & Sons, Ltd.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Labelled Compounds and Radiopharmaceuticals
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
